Real-world data on the efficacy and safety of vedolizumab therapy in patients with inflammatory bowel disease: a retrospective nation-wide cohort study in Singapore

被引：5
|
作者：
Gan, A. T. -M. [1 ]
Chan, W. P. -W. [1 ]
Ling, K. L. [1 ,2 ]
Hartono, L. J. [3 ]
Ong, D. E. [3 ]
Gowans, M. [3 ]
Lin, H. [4 ]
Lim, W. C. [4 ]
Tan, M. T. -K. [5 ]
Ong, J. P. -L. [5 ]
Schwender, B. J. [1 ]
Kong, S. C. [1 ]
Ong, W. C. [1 ]
Lim, T. G. [1 ]
Chuah, S. W. [6 ]
Ooi, C. J. [6 ]
Shim, H. H. [1 ]
机构：
[1] Singapore Gen Hosp, Dept Gastroenterol & Hepatol, Singapore, Singapore
[2] Mt Elizabeth Hosp, Singapore, Singapore
[3] Natl Univ Singapore Hosp, Div Gastroenterol & Hepatol, Singapore, Singapore
[4] Tan Tock Seng Hosp, Dept Gastroenterol & Hepatol, Singapore, Singapore
[5] Changi Gen Hosp, Dept Gastroenterol & Hepatol, Singapore, Singapore
[6] Gleneagles Hosp, Singapore, Singapore
来源：
JOURNAL OF CROHNS & COLITIS | 2019年 / 13卷
关键词：
D O I：
10.1093/ecco-jcc/jjy222.758
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P634
引用
收藏
页码：S434 / S435
页数：2
相关论文
共 50 条
  • [21] The evolving treatment landscape of multiple myeloma in Portugal: A nation-wide retrospective cohort study of real-world clinical practice
    Bergantim, Rui
    Geraldes, Catarina
    Joao, Cristina
    Lucio, Paulo
    Neves, Manuel
    Trigo, Fernanda
    Pedrosa, Hugo
    Ventura, Miguel
    Santos, Susana
    Ramos, Diogo
    EJHAEM, 2024,
  • [22] Benefit of measuring vedolizumab concentrations in inflammatory bowel disease patients in a real-world setting
    Kolehmainen, Sara
    Ylisaukko-Oja, Tero
    Jokelainen, Jari
    Koivusalo, Mirkka
    Jokiranta, T. Sakari
    Sipponen, Taina
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2021, 56 (08) : 906 - 913
  • [23] REAL-WORLD USE OF IMMUNOSUPPRESSIVES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB
    Raluy-Callado, Mireia
    Carroll, Robert
    Curtis, Rebecca
    Khalid, Javaria Mona
    Patel, Haridarshan
    GASTROENTEROLOGY, 2018, 154 (01) : S105 - S106
  • [24] REAL-WORLD USE OF IMMUNOSUPPRESSIVES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB
    Raluy-Callado, Mireia
    Carroll, Robert
    Curtis, Rebecca
    Khalid, Javaria Mona
    Patel, Haridarshan
    INFLAMMATORY BOWEL DISEASES, 2018, 24 : S74 - S75
  • [25] Real world data on effectiveness, safety and therapeutic drug monitoring of vedolizumab in patients with inflammatory bowel disease. A single center cohort
    Buer, Lydia C. T.
    Moum, Bjorn A.
    Cvancarova, Milada
    Warren, David J.
    Bolstad, Nils
    Medhus, Asle W.
    Hoivik, Marte L.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (01) : 41 - 48
  • [26] Efficacy and Safety of Vedolizumab in Elderly Patients with Inflammatory Bowel Disease
    Navaneethan, Udayakumar
    Kommaraju, Kiran Kumar
    Edminster, Timothy
    Zhu, Xiang
    Wilson, Kenneth
    Glover, Sarah C.
    GASTROENTEROLOGY, 2016, 150 (04) : S812 - S812
  • [27] Vedolizumab clearance as a predictor of remission in inflammatory bowel disease: a real-world pharmacokinetic study
    Markovic, S.
    Kralj, D.
    Ivanovski, T. Knezevic
    Kalaba, A.
    Odanovic, O.
    Homsek, A.
    Svorcan, P.
    Vucicevic, K.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I1231 - I1231
  • [28] Real-world evidence on effectiveness and safety of vedolizumab therapy for inflammatory bowel disease in Taiwan: Results from the TSIBD registry (VIOLET Study)
    Wei, S. C.
    Lin, W. C.
    Chang, C. H.
    Tu, C. H.
    Feng, I. C.
    Shieh, M. J.
    Chung, C. S.
    Yen, H. H.
    Chou, J. W.
    Tai, W. C.
    Wong, J. M.
    Liu, Y. H.
    Huang, T. Y.
    Chuang, C. H.
    Tsai, T. J.
    Chiang, F. F.
    Lu, C. Y.
    Hsu, W. H.
    Yu, F. J.
    Chao, T. H.
    Wu, D. C.
    Ho, A. S.
    Lin, H. H.
    Feng, C. L.
    Wu, K. L.
    Wong, M. W.
    Tung, C. C.
    Lin, C. C.
    Chen, C. C.
    Hu, H. M.
    Lu, L. S.
    Wang, H. S.
    Wu, I. C.
    Kuo, H. Y.
    Wu, J. F.
    Shih, H. Y.
    Ni, Y. H.
    Tang, S. L.
    Chang, H. C.
    Chen, P. H.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S428 - S430
  • [29] Real-World Effectiveness of Vedolizumab as Induction Therapy in Inflammatory Bowel Disease: A Meta-Analysis
    Schreiber, Stefan
    Dignass, Axel
    Peyrin-Biroulet, Laurent
    Hather, Greg
    Demuth, Dirk
    Khalid, Javaria
    Loftus, Edward, Jr.
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S24 - S24
  • [30] Real-world Outcomes of Ipilimumab Plus Nivolumab Combination Therapy in a Nation-wide Cohort of Advanced Melanoma Patients in the Netherlands
    van Zeijl, Michiel C. T.
    van Breeschoten, Jesper
    de Wreede, Liesbeth C.
    Wouters, Michel W. J. M.
    Hilarius, Doranne L.
    Blank, Christian U.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette W. P. J.
    de Groot, Jan Willem B.
    Hospers, Geke A. P.
    Kapiteijn, Ellen
    Piersma, Djura
    van Rijn, Rozemarijn S.
    Boer, Marion Stevense-den A.
    van der Veldt, Astrid A. M.
    Vreugdenhil, Gerard
    Boers-Sonderen, Marye J.
    Suijkerbuijk, Karijn P. M.
    Haanen, John B. A. G.
    van den Eertwegh, Alfons J. M.
    JOURNAL OF IMMUNOTHERAPY, 2023, 46 (05) : 197 - 204
12345